🌟 99% Happy customers

📦 Same-day shipping on in-stock items

Catalog Number:
37599
CAS Number:
81403-68-1
Alfuzosin hydrochloride
Purity:
≥ 98% (HPLC)
Synonym(s):
N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)(methyl)amino]propyl]tetrahydro-2-furancarboxamide hydrochloride, 4-Amino-6,7-dimethoxy-2-[methyl[3-[(tetrahydro-2-furoyl)amino]propyl]amino]quinazoline hydrochloride
Documents
$68.20 /100MG
Pack Size Availability Price
Request Bulk Quote
Product Information

Alfuzosin hydrochloride is a potent alpha-1 adrenergic antagonist primarily utilized in the management of benign prostatic hyperplasia (BPH). This compound works by relaxing the muscles in the prostate and bladder neck, facilitating improved urinary flow and reducing symptoms associated with BPH. Its unique mechanism of action makes it particularly effective for patients seeking relief from urinary obstruction due to prostate enlargement. Alfuzosin hydrochloride is recognized for its favorable safety profile and once-daily dosing regimen, enhancing patient compliance and overall treatment satisfaction.

In addition to its primary application in urology, Alfuzosin hydrochloride has been explored in various research contexts, including studies on cardiovascular health and its potential role in managing hypertension. Its ability to selectively target alpha-1 receptors allows for a reduction in blood pressure without significant adverse effects, making it a valuable compound in both clinical and research settings. The compound's versatility and efficacy position it as a preferred choice for healthcare professionals looking to provide effective treatment options for their patients.

Synonyms
N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)(methyl)amino]propyl]tetrahydro-2-furancarboxamide hydrochloride, 4-Amino-6,7-dimethoxy-2-[methyl[3-[(tetrahydro-2-furoyl)amino]propyl]amino]quinazoline hydrochloride
CAS Number
81403-68-1
Purity
≥ 98% (HPLC)
Molecular Formula
C19H27N5O4·HCl
Molecular Weight
425.91
MDL Number
MFCD00879135
PubChem ID
71764
Melting Point
229 °C (dec.)
Appearance
White to almost white powder to crystal
Conditions
Store at 2 - 8 °C
General Information
Synonyms
N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)(methyl)amino]propyl]tetrahydro-2-furancarboxamide hydrochloride, 4-Amino-6,7-dimethoxy-2-[methyl[3-[(tetrahydro-2-furoyl)amino]propyl]amino]quinazoline hydrochloride
CAS Number
81403-68-1
Purity
≥ 98% (HPLC)
Molecular Formula
C19H27N5O4·HCl
Molecular Weight
425.91
MDL Number
MFCD00879135
PubChem ID
71764
Melting Point
229 °C (dec.)
Appearance
White to almost white powder to crystal
Conditions
Store at 2 - 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Alfuzosin hydrochloride is widely utilized in research focused on:

  • Benign Prostatic Hyperplasia (BPH) Treatment: This compound is primarily used in the treatment of BPH, helping to relax the muscles in the prostate and bladder neck, which can improve urine flow and reduce symptoms.
  • Pharmaceutical Formulations: It is commonly incorporated into various oral medications, providing a reliable option for patients requiring long-term management of urinary symptoms.
  • Clinical Research: Alfuzosin hydrochloride is often studied in clinical trials to evaluate its efficacy and safety compared to other alpha-blockers, contributing to advancements in urology.
  • Combination Therapies: Researchers explore its use in combination with other medications to enhance therapeutic outcomes for patients with complex urological conditions.
  • Patient Compliance: The formulation of alfuzosin hydrochloride allows for once-daily dosing, which can improve patient adherence to treatment regimens compared to medications requiring multiple doses.

Citations